Literature DB >> 9917494

Tumor stimulator cell modification by infection with Newcastle Disease Virus: analysis of effects and mechanism in MLTC-CML cultures.

V Schirrmacher1, K Jurianz, C Roth, A Griesbach, R Bonifer, R Zawatzky.   

Abstract

Effects of tumor stimulator cell modification by infection with Newcastle Disease Virus (NDV) are described as analysed in vitro in mixed lymphocyte tumor cell cultures (MLTC). Direct antitumor effects were seen with human melanoma or colon-carcinoma cells in a dose- and time-dependent manner when using live but not UV inactivated virus. When T cell stimulation was measured by [3H]-thymidine uptake, NDV infected tumor stimulator cells did not show an augmentation but rather an inhibitory effect in comparison to non-infected stimulator cells. Virus infected tumor stimulator cells were, however, capable of augmenting the induction of tumor specific cytotoxic T cells in MLTC-CML assays when using murine ESb lymphoma immune cells and syngeneic NDV modified ESb cells as stimulators. A CML stimulatory effect was also shown for NDV modified third party cells and thereof derived conditioned medium. These effects are most likely explained by interferon- which is induced in tumor cells by NDV infection and by interferon-á which is induced in responder cells when stimulated with NDV infected stimulator cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9917494     DOI: 10.3892/ijo.14.2.205

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  4 in total

1.  A recombinant newcastle disease virus with low-level V protein expression is immunogenic and lacks pathogenicity for chicken embryos.

Authors:  T Mebatsion; S Verstegen; L T De Vaan; A Römer-Oberdörfer; C C Schrier
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

2.  In Vitro Synergistic Enhancement of Newcastle Disease Virus to 5-Fluorouracil Cytotoxicity against Tumor Cells.

Authors:  Ahmed M Al-Shammari; Marwa I Salman; Yahya D Saihood; Nahi Y Yaseen; Khansaa Raed; Hiba Kareem Shaker; Aesar Ahmed; Aseel Khalid; Ahlam Duiach
Journal:  Biomedicines       Date:  2016-01-29

Review 3.  Breaking Therapy Resistance: An Update on Oncolytic Newcastle Disease Virus for Improvements of Cancer Therapy.

Authors:  Volker Schirrmacher; Stefaan van Gool; Wilfried Stuecker
Journal:  Biomedicines       Date:  2019-08-30

Review 4.  Therapeutic potential of oncolytic Newcastle disease virus: a critical review.

Authors:  Shay Tayeb; Zichria Zakay-Rones; Amos Panet
Journal:  Oncolytic Virother       Date:  2015-03-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.